AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Letsure 2.5 Tablet

Prescription Icon
Prescription Required

Marketer

Astraea Life Sciences Pvt Ltd

Salt Composition

Letrozole (2.5mg)

Overview Letsure 2.5 Tablet

Postmenopausal women with breast cancer may find relief with Letsure 2.5 Tablet. This medication can be administered independently or in conjunction with other therapies like surgery or radiation. It's also indicated for advanced breast cancer, potentially hindering metastasis. Letsure 2.5 Tablet can be ingested with or without food, always following your doctor's prescribed dosage and regimen for optimal results. Dosage frequency is tailored to individual needs and treatment goals. Continuous use, as directed by your physician, is crucial. Commonly reported side effects encompass hot flushes, tiredness, excessive perspiration, and elevated cholesterol. Report any concerning side effects to your doctor; management strategies may be available. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Complete disclosure of all other medications is essential, as interactions can influence Letsure 2.5 Tablet's efficacy. Pregnant or breastfeeding women should consult their physician. Baseline and ongoing blood tests, possibly assessing vitamin D levels and bone density, may be conducted during treatment.

Uses of Letsure 2.5 Tablet

Managing breast cancer

Major Benefits of Letsure 2.5 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letsure 2.5mg tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Letsure 2.5 Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letsure 2.5 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Letsure 2.5mg tablets can be administered with or without food, however, consistency in timing is recommended.

How Letsure 2.5 Tablet works:

Estrogen production is reduced by Letsure 2.5 Tablet, an aromatase inhibitor. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Letsure 2.5 Tablet can be taken with alcohol without adverse reactions.

PregnancyPregnancyUNSAFE

Using Letsure 2.5 Tablet during pregnancy is strongly discouraged due to substantial risks. Pregnant women should consult their physician; research in both animal and human studies has revealed significant adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

The use of Letsure 2.5 Tablet while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Letsure 2.5 Tablet may cause drowsiness, blurred vision, dizziness, and reduced alertness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

The use of Letsure 2.5 Tablet is considered safe for individuals with kidney disease; no dosage modification is typically necessary. Data regarding its use in patients with end-stage renal disease, however, is scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Letsure 2.5 Tablets. Dosage modification may be necessary. A physician's consultation is recommended.

What if you forget to take Letsure 2.5 Tablet :

Should you forget to take your Letsure 2.5 Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Letsure 2.5 Tablet

LabelValue
Type of Compound Benzophenone-related compound
Potential for Dependence None.
Type of Medication Cancer therapeutics

FAQs on Letsure 2.5 Tablet

Femara 2.5mg tablets function as an aromatase inhibitor. This medication is commonly used in postmenopausal women with breast cancer, following menopause, surgery, or chemotherapy.
The medication Letsure 2.5 Tablet functions as an aromatase inhibitor, a class of anti-estrogen drugs. Its mechanism involves suppressing estrogen synthesis by inhibiting the aromatase enzyme, crucial for estrogen production. This is beneficial as estrogen fuels the growth of certain breast cancers, termed "estrogen-dependent cancers." Consequently, lowering estrogen levels can hinder tumor progression.
For advanced breast cancer or cancer that has metastasized, Letsure 2.5 Tablet should be continued until tumor progression is observed. Following tamoxifen therapy or surgery, Letsure 2.5 Tablet is prescribed for five years, or until recurrence, whichever occurs sooner. Alternatively, a sequential regimen of two years of Letsure 2.5 Tablet followed by three years of tamoxifen may be employed.
Concurrent use of irbesartan and Letsure 2.5 Tablet is permissible. Nevertheless, diligent blood pressure monitoring is advised, as Letsure 2.5 Tablet can elevate blood pressure. Seek medical attention if blood pressure management proves difficult.
While rare, Letsure 2.5 Tablet has been associated with the potential development of cataracts. Therefore, prompt medical attention is advised should you develop blurry vision or eye discomfort.
Experiencing hot flashes may indicate a common side effect of Letsure 2.5 Tablet, linked to reduced estrogen. These episodes typically lessen as your body adapts to the medication. For some, however, they might persist throughout treatment, subsiding only after several months. If these symptoms are significantly disruptive, seek medical advice for potential management options.
Rarely, Letsure 2.5 Tablet may cause serious adverse events such as stroke, angina pectoris, myocardial infarction, thromboembolic complications, cataracts, osteoporosis, and severe dermatological reactions.
Bone thinning (osteoporosis) can occur with Letsure 2.5 Tablet use, a consequence of reduced estrogen. To monitor for this, your physician might assess your bone density before, throughout, and following treatment.
The Ministry of Health and Family Welfare designates Letsure 2.5 Tablet solely for inducing ovulation in women with anovulatory infertility.
Letsure 2.5 Tablet
119
MRP 138
13% off